Reuters logo
BRIEF-CTI Biopharma announces european medicines agency validation of Pacritinib
July 13, 2017 / 8:29 PM / 2 months ago

BRIEF-CTI Biopharma announces european medicines agency validation of Pacritinib

July 13 (Reuters) - Cti Biopharma Corp

* CTI Biopharma announces european medicines agency validation of pacritinib marketing authorization application for patients with myelofibrosis who have thrombocytopenia

* CTI Biopharma Corp - announced that european medicines agency (ema) has validated marketing authorization application (maa) for pacritinib

* Says if authorized, pacritinib would be granted a marketing license valid in all 28 eu member states Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below